nsulin antibodies in patients with type 2 diabetic receiving recombinant human insulin injection : A report of 12 cases

Maria Mavromati a,b,1,2 Myriam Amsallem a,1,2,∗ Christel Jublanc a,2 Eric Bruckert a,2 Laurence Leenhardt c,2 Xavier Girerd a,2 a Department of Endocrinology and Metabolic Diseases, La Pitié-Salpêtrière Hospital, boulevard de l’Hôpital, 75013 Paris, France b Department of Endocrinology and Diabetes, University Hospital of Geneva, Geneva, Switzerland c Department of Nuclear Medicine, La Pitié-Salpêtrière Hospital, boulevard de l’Hôpital, 75013 Paris, France

[1]  A. Shimatsu,et al.  Development of insulin antibodies and changes in titers over a long-term period in patients with type 2 diabetes. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[2]  Shenmin Zhang,et al.  Hypoglycemia due to insulin binding antibodies in a patient with insulin-treated type 2 diabetes and Graves’ disease , 2013, Endocrine.

[3]  E. Renard,et al.  Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control , 2009, Diabetes/metabolism research and reviews.

[4]  S. Ito,et al.  Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies. , 2009, Diabetes research and clinical practice.

[5]  S. Fineberg,et al.  Immunological responses to exogenous insulin. , 2007, Endocrine reviews.

[6]  H. Itoh,et al.  Insulin lispro reduces insulin antibodies in a patient with type 2 diabetes with immunological insulin resistance. , 2003, Diabetes research and clinical practice.

[7]  T. Pieber,et al.  Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes. , 2000, Diabetes care.

[8]  M. Knip,et al.  Severe Antibody-Mediated Human Insulin Resistance: Successful Treatment With the Insulin Analog Lispro: A case report , 1997, Diabetes Care.

[9]  G. Schernthaner,et al.  Immunogenicity and Allergenic Potential of Animal and Human Insulins , 1993, Diabetes Care.

[10]  N. Fineberg,et al.  Immunogenicity of recombinant DNA human insulin , 1983, Diabetologia.

[11]  J. Davidson,et al.  Immunologic Insulin Resistance , 1978, Diabetes.

[12]  F. C. Lowell,et al.  Insulin antibodies in the pathogenesis of insulin allergy and resistance. , 1977, The American journal of medicine.

[13]  T. Zhao,et al.  Frequent reoccurrence of hypoglycemia in a type 2 diabetic patient with insulin antibodies. , 2010, Molecular diagnosis & therapy.

[14]  C. Faiman,et al.  Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia? , 1997, Endocrine.